Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 5-Year Average (19.6), the stock would be worth R$-6.57 (321% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -8.9 | R$2.97 |
0%
|
| 5-Year Average | 19.6 | R$-6.57 |
-321%
|
| Industry Average | 7.8 | R$-2.62 |
-188%
|
| Country Average | 13.4 | R$-4.49 |
-251%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| BR |
|
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
|
452.4m BRL | -8.9 | -5.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 19.9 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 12.6 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 29.8 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 16.6 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 19.8 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 21.1 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 9.9 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | -51.3 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 14.9 | 13.9 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.2 |
| Median | 13.4 |
| 70th Percentile | 24.4 |
| Max | 1 667.2 |
Other Multiples
Centro de Imagem Diagnosticos SA
Glance View
Centro de Imagem Diagnósticos SA is a holding company, which engages in the provision of medical diagnostic services. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2016-10-28. The firm focuses on managing medical and diagnostic laboratories. The firm offers medical and diagnostic imaging services, such as biopsy, bone densitometry, laboratory tests, digital mammography, Doppler echocardiography, positron emission tomography (PET) scan for oncology, X-radiation (X-rays), magnetic resonance imaging (MRI), computer tomography (CT), prenatal tests and ultrasounds. The firm operates a number of units in the states of Parana, Para, Minas Gerais, Bahia, Espirito Santo, Rio de Janeiro, Rio Grande do Norte and Sao Paulo, among others, Brazil.
